SCHEMBL30746443

SCHEMBL30746443

CCc1ccc(Nc2cncc(Cc3ccnc(N)c3F)c2C)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ MAP2K2 P36507 1/20 0.35
▸ MAP2K1 Q02750 1/20 0.35
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ NOS2 P35228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985130 1.00 MAP2K2 (0.35) MAP2K2MAP2K1NOS3NOS1NOS2
SCHEMBL30746577 0.89 — —
SCHEMBL26984964 0.89 — —
SCHEMBL26985336 0.89 DHFR (0.34) —
SCHEMBL26984875 0.89 KDM4E (0.35) MAP2K2MAP2K1
SCHEMBL30746454 0.89 KDM4E (0.35) MAP2K2MAP2K1
SCHEMBL30746604 0.89 DHFR (0.34) —
SCHEMBL26984845 0.87 MAPK1 (0.35) MAP2K2MAP2K1
SCHEMBL30746672 0.87 MAPK1 (0.35) MAP2K2MAP2K1
SCHEMBL26984868 0.87 NUDT1 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback